Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest biotechnology Stories

2014-04-08 08:30:44

ST. LOUIS, April 8, 2014 /PRNewswire/ -- ISTO Technologies, Inc. ("ISTO," the "Company"), a privately-held regenerative medicine company applying its proprietary platform technologies to orthopedic and spine applications, has appointed Phillip W. Kuhn, a medical technology executive with over three decades of industry experience, as the Company's Chief Commercial Officer. In this newly created role, Mr. Kuhn will oversee ISTO's commercial strategy, including the execution of...

2014-04-08 08:30:32

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/92nl6r/opportunities_in) has announced the addition of the "Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017" [http://www.researchandmarkets.com/research/92nl6r/opportunities_in ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Embryonic stem cells are stem cells...

2014-04-08 08:30:15

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/92wf5v/animal) has announced the addition of a new report "Animal Biotechnology - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/92wf5v/animal ] to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes and evaluates animal biotechnology and its application in...

2014-04-08 08:30:12

DUBLIN, April 8, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular) has announced the addition of the "Cancer Molecular Biomarkers 2014: A Global Market Study" [http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Technological advances in molecular biology over the last decade are accelerating...

2014-04-08 08:30:06

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tnkqbn/cancer_molecular) has announced the addition of the "Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014" [http://www.researchandmarkets.com/research/tnkqbn/cancer_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cancer diagnostics is one of the most dynamic medical...

2014-04-07 16:25:29

SAN DIEGO, April 7, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced the addition of Ian B. Walters, M.D., MBA., a translational oncology and immunology expert. Dr. Walters was most recently an executive at Bristol Myers Squibb (BMS) where he led oncology drug development programs, large international matrix teams, and strategic transactions. He...

2014-04-07 16:05:15

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas, which are extremely difficult to...

2014-04-07 12:32:58

SHANGHAI, April 7, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, today announced that it has received an honorable mention award at the International Society for Pharmaceutical Engineering's (ISPE) 2014 Facility of the Year Awards for the company's recently completed cGMP cell-culture-based biologics production facility in Wuxi. These...

2014-04-07 11:14:25

UH Math collaborates with Rice on synthetic gene circuit A long-standing challenge in synthetic biology has been to create gene circuits that behave in predictable and robust ways. Mathematical modeling experts from the University of Houston (UH) collaborated with experimental biologists at Rice University to create a synthetic genetic clock that keeps accurate time across a range of temperatures. The findings were published in a recent issue of the Proceedings of the National Academy of...

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »